Inclusion on the list of medicines refundable by National Health Insurance and approved for hospital use.
-
Clinical Benefit
Substantial
The actual benefit of this product is substantial.
Clinical Added Value
no clinical added value
In the absence of a demonstration of superiority of CITRAFLEET over other colonic preparations, CITRAFLEET does not provide an improvement in actual benefit in the performance of gastrointestinal endoscopy (IAB V). CITRAFLEET is an additional diagnostic agent.